>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
GnRH-a和口服避孕药辅助腹腔镜手术对重度子宫内膜异位症患者主观症状评分及性激素水平的影响
作者:杨德红1  邹莉1  李燕茹2 
单位:1. 云南省第一人民医院 生殖妇科, 云南 昆明 650032;
2. 云南省交通中心医院 妇产科, 云南 昆明 650042
关键词:子宫内膜异位症 促性腺激素释放激素激动剂 口服避孕药 腹腔镜手术 
分类号:R711.71
出版年·卷·期(页码):2017·36·第三期(390-394)
摘要:

目的:研究促性腺激素释放激素激动剂(GnRH-a)和口服避孕药辅助腹腔镜手术对重度子宫内膜异位症患者主观症状评分及性激素水平的影响。方法:选取接受腹腔镜手术并经病理确诊的重度子宫内膜异位症患者76例,用随机数表法分为口服避孕药组和GnRH-a组各38例。GnRH-a组患者术后腹壁皮下注射GnRH-a,口服避孕药组患者术后口服去氧孕烯炔雌醇片。比较两组患者的主观症状评分、性激素水平、妊娠率、复发率和不良反应。结果:术后3个月两组患者的卵泡刺激素(FSH)、雌二醇(E2)和黄体生成素(LH)水平均明显下降,GnRH-a组患者的E2、FSH和LH水平低于口服避孕药组(P<0.05);术后3个月两组患者的盆腔症状评分、体征评分和总主观症状评分明显下降,GnRH-a组患者以上评分低于口服避孕药组(P<0.05);术后15个月GnRH-a组患者的复发率低于口服避孕药组(P<0.05),两组妊娠率比较差异无统计学意义(P>0.05);口服避孕药组患者不良反应发生率低于GnRH-a组(P<0.05)。停药后患者症状逐渐消失,术后4个月两组患者均恢复正常月经。结论:GnRH-a辅助腹腔镜手术治疗重度子宫内膜异位症较口服避孕药辅助腹腔镜手术效果更佳,可明显降低患者的性激素水平、主观症状评分和复发率,值得在临床推广应用。

Objective:To study the effect of GnRH-a and oral contraceptive assisted laparoscopic surgery on subjective symptom scores and sex hormone levels in patients with severe endometriosis. Methods:Seventy-six patients with severe endometriosis confirmed by laparoscopy were divided into oral contraceptive group and GnRH-a group using a random number table method with 38 in each group. After the operation, patients in GnRH-a group were treated with subcutaneous injection of GnRH-a, and patients in contraceptive oral group took desogestrel and ethinylestradiol tablets orally. The subjective symptom score, sex hormone level, pregnancy rate, recurrence rate and adverse reactions were compared between the two groups. Results:Three months after operation, the levels of E2, FSH and LH were significantly decreased in the two groups, the levels of which in GnRH-a group were lower than those in contraceptive group(P<0.05). After 3 months, the pelvic symptoms, physical signs and total subjective symptom scores decreased significantly, which were lower in GnRH-a group than those in oral contraceptive group(P<0.05). Fifteen months after operation, the recurrence rate of group GnRH-a was lower than that of oral contraceptive group(P<0.05). There was no significant difference in pregnancy rates between the two groups(P>0.05). The incidence of adverse reactions in the oral contraceptive group was lower than that in GnRH-a group(P<0.05). After the withdrawal of the treatment, the symptoms disappeared gradually,and 4 months after operation, all the patients in the two groups returned to a regular menstrual cycle. Conclusion:GnRH-a assisted laparoscopic surgery in the treatment of severe endometriosis is better than oral contraceptive assisted laparoscopic surgery. It can significantly reduce the level of sex hormones, subjective symptom score and recurrence rate, which is worthy of clinical application.

参考文献:

[1] 陈观美,徐莉莉,杨武.重度子宫内膜异位症术后GnRH-a与达英35联合治疗的疗效比较[J].重庆医学,2016,45(10):1387-1389.
[2] STREULI I,de ZIEGLER D,SANTULLI P,et al.An update on the pharmacological management of endometriosis[J].Expert Opin Pharmacother,2013,14(3):291-305..
[3] MORELLI M,ROCCA M L,VENTURELLA R,et al.Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue(GnRH-a)administration in premenopausal women suffering from adenomyosis or endometriosis:a retrospective study[J].Gynecol Endocrinol,2013,29(4):305-308.
[4] 中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊治指南[J].中华妇产科杂志,2015,3:101-169.
[5] 胡晓军,刘玉玲,党群.重度子宫内膜异位症腹腔镜术后应用GnRHa及反向添加疗法的临床效果[J].实用医学杂志,2014,30(4):557-560.
[6] 王飞,龚萍,何钒,等.腹壁子宫内膜异位症的针吸细胞学诊断[J].现代医学,2012,40(6):679-681.
[7] 许希中.子宫内膜异位症伴不孕患者腹腔镜术后不同治疗方法对妊娠率的影响[J].重庆医学,2014,43(5):611-613.
[8] 郑兴宗.腹腔镜手术分别联合GnRH-a与孕三烯酮治疗子宫内膜异位症的效果比较[J].实用药物与临床,2014,17(3):378-381.
[9] 向亚利,毛平.腹腔镜下个体化手术联合促性腺激素释放激素激动剂治疗子宫内膜异位症75例疗效观察[J].中国内镜杂志,2015,21(1):59-62.
[10] 刘维星.腹腔镜手术联合促性腺激素释放激素激动剂治疗中重度子宫内膜异位症的临床研究[J].中国计划生育和妇产科,2015,7(2):27-31.
[11] 王彦珍,郝红燕,黄丽,等.不同GnRH-a降调节方案用于子宫内膜异位症合并不育者的体外受精-胚胎移植研究[J].重庆医学,2012,41(4):333-336.
[12] 宋飞銮,蔡安利,黄丁,等.促性腺激素释放激素激动剂联合去氧孕烯炔雌醇治疗重度子宫内膜异位症的疗效观察[J].中国全科医学,2014,17(27):3245-3248.
[13] 刘长青,秦爱新,姜芳芳,等.促性腺激素释放激素激动剂联合坤泰胶囊治疗中重度子宫内膜异位症的临床观察[J].中国中西医结合杂志,2014,34(11):1276-1291.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414586 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364